Our Proposed Development Solutions

We believe that our drug development candidates address many of the shortcomings of existing pain treatments by providing one or all of the following characteristics:

Shortcomings of Available Pain Products		TheraQuest Pain Product Solutions
Abuse Prone Opioids Vulnerable to Alcohol Dose Dumping Q8-12H Sustained Release Opioids Suboptimal Side-effect Profile Narrow Spectrum Analgesia Short Duration of Postsurgical Pain Relief Inadequate Treatments of Neuropathic Pain Opioid Analgesic Tolerance Inadequate Pain Relief		Abuse Deterrent Opioids Resistant to Alcohol Dose Dumping True Q24H Sustained Release Opioids Superior Side-effect Profile Broad Spectrum Analgesia Prolonged Postsurgical Pain Relief Triple Mechanism of Action in Neuropathic Pain Effective in Morphine Tolerant Patients Synergy with Opioid Analgesics